Pelvic inflammatory disease (PID) is a common and potentially serious infection of the female reproductive organs, primarily affecting the uterus, fallopian tubes, and ovaries. PID poses significant risks for long-term complications, including infertility, ectopic pregnancy, and chronic pelvic pain. This review provides a comprehensive overview of PID, encompassing its etiology, pathophysiology, clinical presentation, diagnostic approaches, and management strategies.

Etiology and Pathophysiology: PID typically results from ascending infection of the upper genital tract, primarily caused by sexually transmitted pathogens such as Chlamydia trachomatis and Neisseria gonorrhoeae. Other microorganisms, including anaerobic bacteria and genital mycoplasmas, may also contribute to the development of PID. The pathophysiology of PID involves mucosal injury, disruption of the cervical barrier, and subsequent microbial invasion of the endometrium, fallopian tubes, and adjacent structures. Inflammatory responses lead to tissue damage, fibrosis, and the formation of adhesions, impairing reproductive function and increasing the risk of chronic pelvic pain.

Clinical Presentation: The clinical presentation of PID varies widely in severity and may range from asymptomatic infection to severe systemic illness. Common symptoms include lower abdominal or pelvic pain, vaginal discharge, dyspareunia, dysuria, abnormal uterine bleeding, and fever. Physical examination findings may include cervical motion tenderness, uterine or adnexal tenderness, and palpable adnexal masses. However, PID can manifest with atypical or subtle symptoms, particularly in adolescents and individuals with subclinical infections, necessitating a high index of suspicion for diagnosis.

Diagnostic Evaluation: The diagnosis of PID is primarily based on clinical findings, supplemented by laboratory testing and imaging studies. Diagnostic criteria include the presence of lower genital tract inflammation (e.g., cervical discharge, cervical friability) in combination with pelvic organ tenderness on examination. Laboratory tests such as nucleic acid amplification tests (NAATs) for Chlamydia and gonorrhea, complete blood count, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) may aid in confirming the diagnosis and assessing the severity of infection. Imaging modalities such as transvaginal ultrasound or magnetic resonance imaging (MRI) may be indicated to evaluate for complications such as tubo-ovarian abscess or pelvic free fluid.

Management Strategies: The management of PID involves antimicrobial therapy to eradicate the causative pathogens, alleviate symptoms, and prevent long-term sequelae. Empirical antibiotic regimens targeting common pathogens include broad-spectrum coverage against both gram-negative and anaerobic bacteria. Treatment should be initiated promptly, preferably on an outpatient basis for mild to moderate cases, with consideration for inpatient admission in severe cases, immunocompromised patients, or those at risk of complications. Adjunctive measures such as pain management, supportive care, and partner treatment are essential components of PID management. Follow-up evaluation is crucial to assess treatment response, monitor for complications, and provide counseling on the prevention of recurrent infections and STI screening.

Conclusion: Pelvic inflammatory disease is a significant cause of morbidity among women of reproductive age, with potential long-term consequences for fertility and reproductive health. Early recognition and prompt management are essential to reduce the risk of complications and improve outcomes. By understanding the etiology, pathophysiology, clinical presentation, diagnostic approaches, and management principles of PID, healthcare providers can effectively diagnose, treat, and prevent the sequelae of this common gynecological condition. Continued efforts to promote sexual health education, enhance STI screening, and optimize PID management strategies are critical for reducing the burden of PID and its associated complications.